These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37355889)

  • 1. Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.
    Hautecloque-Raysz G; Sellal F; Bousiges O; Phillipi N; Blanc F; Cretin B
    J Alzheimers Dis; 2023; 94(3):1057-1074. PubMed ID: 37355889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putting the Brakes on Accelerated Cognitive Decline in Alzheimer's Disease with Epileptic Activity.
    Vossel K
    J Alzheimers Dis; 2023; 94(3):1075-1077. PubMed ID: 37522212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?
    Cretin B; Sellal F; Philippi N; Bousiges O; Di Bitonto L; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016 Apr; 52(3):1125-33. PubMed ID: 27104892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
    Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
    Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy in Early Onset Alzheimer's Disease.
    Haoudy S; Jonveaux T; Puisieux S; Epstein J; Hopes L; Maillard L; Aron O; Tyvaert L
    J Alzheimers Dis; 2022; 85(2):615-626. PubMed ID: 34864663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications.
    Altuna M; Olmedo-Saura G; Carmona-Iragui M; Fortea J
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0.
    Ritchie CW; Muniz-Terrera G; Kivipelto M; Solomon A; Tom B; Molinuevo JL
    J Prev Alzheimers Dis; 2020; 7(1):8-13. PubMed ID: 32010920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
    Rosenfeld WE; Nisman A; Ferrari L
    Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizures and epileptiform activity in the early stages of Alzheimer disease.
    Vossel KA; Beagle AJ; Rabinovici GD; Shu H; Lee SE; Naasan G; Hegde M; Cornes SB; Henry ML; Nelson AB; Seeley WW; Geschwind MD; Gorno-Tempini ML; Shih T; Kirsch HE; Garcia PA; Miller BL; Mucke L
    JAMA Neurol; 2013 Sep; 70(9):1158-66. PubMed ID: 23835471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis.
    Lee SK; Heo K; Kim SE; Lee SA; Elmoufti S; Laloyaux C; Hur B
    Adv Ther; 2021 Jul; 38(7):4082-4099. PubMed ID: 34155568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with psychogenic nonepileptic seizures and suspected epilepsy: An antiseizure medication reduction study.
    Tavakoli Yaraki P; Paredes-Aragon E; Joe Yu Y; AlKhateeb M; Mirsattari SM
    Epilepsy Behav; 2023 Apr; 141():109116. PubMed ID: 36807990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do we know how to diagnose epilepsy early in Alzheimer's disease?
    Cretin B; Philippi N; Bousiges O; Dibitonto L; Sellal F; Martin-Hunyadi C; Blanc F
    Rev Neurol (Paris); 2017 Jun; 173(6):374-380. PubMed ID: 28501143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis.
    Corniello C; Dono F; Evangelista G; Consoli S; De Angelis S; Cipollone S; Liviello D; Polito G; Melchiorre S; Russo M; Granzotto A; Anzellotti F; Onofrj M; Thomas A; Sensi SL
    Seizure; 2023 Jul; 109():62-67. PubMed ID: 37267668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
    Rosenfeld WE; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Krauss GL; Sperling MR; Vossler DG; Klein P; Wechsler R
    Epilepsia; 2021 Dec; 62(12):3016-3028. PubMed ID: 34633074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.
    Frölich L; Wunderlich G; Thamer C; Roehrle M; Garcia M; Dubois B
    Alzheimers Res Ther; 2019 Feb; 11(1):18. PubMed ID: 30755255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One.
    Cretin B; Bousiges O; Hautecloque G; Philippi N; Blanc F; Dibitonto L; Martin-Hunyadi C; Sellal F
    Front Neurol; 2021; 12():623777. PubMed ID: 34413819
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study.
    DiFrancesco JC; Tremolizzo L; Polonia V; Giussani G; Bianchi E; Franchi C; Nobili A; Appollonio I; Beghi E; Ferrarese C
    J Alzheimers Dis; 2017; 60(4):1267-1274. PubMed ID: 28968234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.